{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:42:58Z","timestamp":1767109378365,"version":"build-2065373602"},"reference-count":58,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T00:00:00Z","timestamp":1679097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Autochthonous hepatitis E (HEV) cases have been increasingly recognized and reported in Europe, caused predominantly by the zoonotic HEV genotype 3. The clinical picture is highly variable, from asymptomatic to acute severe or prolonged hepatitis in immunocompromised patients. The main route of transmission to humans in Europe is the ingestion of undercooked pork meat. Transfusion-transmitted HEV infections have also been reported. The aim of the study was to determine the HEV epidemiology and risk in the Finnish blood donor population. A total of 23,137 samples from Finnish blood donors were screened for HEV RNA from individual samples and 1012 samples for HEV antibodies. Additionally, laboratory-confirmed hepatitis E cases in 2016\u20132022 were extracted from national surveillance data. The HEV RNA prevalence data was used to estimate the risk of transfusion transmission of HEV in the Finnish blood transfusion setting. Four HEV RNA-positive were found, resulting in 1:5784 (0.02%) RNA prevalence. All HEV RNA-positive samples were IgM-negative, and genotyped samples represented genotype HEV 3c. HEV IgG seroprevalence was 7.4%. From the HEV RNA rate found in this study and data on blood component usage in Finland in 2020, the risk estimate for a severe transfusion-transmitted HEV infection is 1:1,377,000 components or one in every 6\u20137 years. In conclusion, the results indicate that the risk of transfusion-transmitted HEV (HEV TTI) in Finland is low. However, continuous follow-up of the HEV epidemiology in relation to the transfusion risk landscape in Finland is necessary, as well as promoting awareness in the medical community of the small risk for HEV TTI, especially for immunocompromised patients.<\/jats:p>","DOI":"10.3390\/pathogens12030484","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T04:05:23Z","timestamp":1679285123000},"page":"484","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hepatitis E Virus in Finland: Epidemiology and Risk in Blood Donors and in the General Population"],"prefix":"10.3390","volume":"12","author":[{"given":"Jaana","family":"M\u00e4tt\u00f6","sequence":"first","affiliation":[{"name":"Finnish Red Cross Blood Service, 01730 Vantaa, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niina","family":"Putkuri","sequence":"additional","affiliation":[{"name":"Finnish Red Cross Blood Service, 01730 Vantaa, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruska","family":"Rimhanen-Finne","sequence":"additional","affiliation":[{"name":"Finnish Institute for Health and Welfare, 00100 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4ivi","family":"Laurila","sequence":"additional","affiliation":[{"name":"Finnish Institute for Health and Welfare, 00100 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonna","family":"Clancy","sequence":"additional","affiliation":[{"name":"Finnish Red Cross Blood Service Biobank, 01730 Vantaa, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarkko","family":"Ihalainen","sequence":"additional","affiliation":[{"name":"Finnish Red Cross Blood Service, 01730 Vantaa, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Ekblom-Kullberg","sequence":"additional","affiliation":[{"name":"Finnish Red Cross Blood Service, 01730 Vantaa, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.3748\/wjg.v22.i31.7030","article-title":"Hepatitis E: Discovery, global impact, control and cure","volume":"22","author":"Khuroo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/tme.12405","article-title":"Hepatitis E: The current state of play","volume":"27","author":"Anckorn","year":"2017","journal-title":"Transfus. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcv.2016.06.010","article-title":"Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014\/15","volume":"82","author":"Adlhoch","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"30561","DOI":"10.2807\/1560-7917.ES.2017.22.26.30561","article-title":"Hepatitis E virus infection in Europe: Surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015","volume":"22","author":"Aspinall","year":"2017","journal-title":"Euro Surveill."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Horvatits, T., Schulze zur Wiesch, J., L\u00fctgehetmann, M., Lohse, A.W., and Pischke, S. (2019). The clinical perspective on hepatitis E. Viruses, 11.","DOI":"10.3390\/v11070617"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3201\/eid2006.140140","article-title":"New hepatitis E virus genotype in camels, the Middle East","volume":"20","author":"Woo","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2015.10.048","article-title":"Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jcv.2013.08.030","article-title":"Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals","volume":"58","author":"Chaussade","year":"2013","journal-title":"J. Clin. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00430-011-0210-5","article-title":"Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs","volume":"201","author":"Krumbholz","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3748\/wjg.v28.i1.47","article-title":"Transfusion-transmitted hepatitis E: What we know so far?","volume":"28","author":"Cheung","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: A prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5694\/mja16.01090","article-title":"First confirmed case of transfusion-transmitted hepatitis E in Australia","volume":"206","author":"Hoad","year":"2017","journal-title":"Med. J. Aust."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/trf.13498","article-title":"Virology, serology, and demography of hepatitis E viremic blood donors in South East England","volume":"56","author":"Tedder","year":"2016","journal-title":"Transfusion"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268820001429","article-title":"Hepatitis E virus and blood transfusion safety","volume":"148","author":"Bi","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood-2013-09-524348","article-title":"Hepatitis E transmission by transfusion of intercept blood system-treated plasma","volume":"123","author":"Hauser","year":"2014","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000499121","article-title":"Blood donor screening for hepatitis E virus in the European union","volume":"46","author":"Boland","year":"2019","journal-title":"Transfus. Med. Hemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1800386","DOI":"10.2807\/1560-7917.ES.2019.24.10.1800386","article-title":"Hepatitis E virus in blood donors in England, 2016 to 2017: From selective to universal screening","volume":"24","author":"Harvala","year":"2019","journal-title":"Euro Surveill."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/trf.13978","article-title":"Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands","volume":"57","author":"Janssen","year":"2017","journal-title":"Transfusion"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1111\/trf.13757","article-title":"Hepatitis E virus infection in the Irish blood donor population","volume":"56","author":"Boland","year":"2016","journal-title":"Transfusion"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/trf.15058","article-title":"Hepatitis E virus blood donor NAT screening: As much as possible or as much as needed?","volume":"59","author":"Vollmer","year":"2019","journal-title":"Transfusion"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3201\/eid2011.140516","article-title":"Hepatitis E virus infections in blood donors, France","volume":"20","author":"Gallian","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/vox.13375","article-title":"Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France","volume":"117","author":"Pillonel","year":"2022","journal-title":"Vox Sang."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1700616","DOI":"10.2807\/1560-7917.ES.2018.23.35.1700616","article-title":"Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016","volume":"23","author":"Niederhauser","year":"2018","journal-title":"Euro Surveill."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3201\/eid2801.211466","article-title":"Effect of hepatitis E virus RNA universal blood donor screening, Catalonia, Spain, 2017\u20132020","volume":"28","author":"Bes","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/trf.13700","article-title":"Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors","volume":"56","author":"Holm","year":"2016","journal-title":"Transfusion"},{"key":"ref_26","unstructured":"Kantala, T. (2017). Presence of Hepatitis E Virus (HEV) and Markers for HEV Infection in Production Swine, Human Patients with Unexplained Hepatitis, and Veterinarians in Finland. [PhD Thesis, University of Helsinki]."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/zph.12312","article-title":"Hepatitis E virus antibodies in finnish veterinarians","volume":"64","author":"Kantala","year":"2017","journal-title":"Zoonoses Public Health"},{"key":"ref_28","first-page":"2169","article-title":"Suomalaismiehen kotoper\u00e4inen E-hepatiittitartunta [A domestic human case of hepatitis E in Finland]","volume":"129","author":"Kettunen","year":"2013","journal-title":"Duodecim"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1055\/s-0038-1649950","article-title":"Hepatitis E virus: No evidence of parenteral transmission in Finland","volume":"74","author":"Ebeling","year":"1995","journal-title":"Thromb Haemost."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijfoodmicro.2017.06.029","article-title":"Porcine blood used as ingredient in meat productions may serve as a vehicle for hepatitis E virus transmission","volume":"257","author":"Boxman","year":"2017","journal-title":"Int. J. Food Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1128\/JCM.00542-06","article-title":"Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens","volume":"44","author":"Nix","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0","volume":"24","author":"Tamura","year":"2007","journal-title":"Mol. Biol. Evol."},{"key":"ref_33","first-page":"406","article-title":"The neighbor-joining method: A new method for reconstructing phylogenetic trees","volume":"4","author":"Saitou","year":"1987","journal-title":"Mol. Biol. Evol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/vox.12559","article-title":"Hepatitis E virus RNA in Australian blood donors: Prevalence and risk assessment","volume":"112","author":"Hoad","year":"2017","journal-title":"Vox Sang."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/vox.12887","article-title":"Prevalence of hepatitis E viraemia among blood donors: A systematic review","volume":"115","author":"Goel","year":"2020","journal-title":"Vox Sang."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/jvh.13161","article-title":"Hepatitis E virus prevalence in Flemish blood donors","volume":"26","author":"Vercouter","year":"2019","journal-title":"J. Viral. Hepat."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fischer, C., Hofmann, M., Danzer, M., Hofer, K., Kaar, J., and Gabriel, C. (2015). Seroprevalence and incidence of hepatitis E in blood donors in Upper Austria. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119576"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcv.2019.01.005","article-title":"Performance characteristics of the VIDAS\u00ae ANTI-HEV IgM and IgG assays","volume":"112","author":"Abravanel","year":"2019","journal-title":"J. Clin. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/17843286.2019.1655245","article-title":"Are VIDAS\u00ae anti-HEV IgM and IgG assays fit for reliable diagnosis of hepatitis E virus infections?","volume":"76","author":"Cattoir","year":"2019","journal-title":"Comparison & case story telling. Acta Clin. Belg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10393-020-01509-5","article-title":"Foodborne zoonoses common in hunted wild boars","volume":"17","author":"London","year":"2020","journal-title":"Ecohealth"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12560-020-09442-0","article-title":"Antibodies against hepatitis E virus (HEV) in European moose and white-tailed deer in Finland","volume":"12","author":"Loikkanen","year":"2020","journal-title":"Food Environ. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/trf.13976","article-title":"Hepatitis E risks: Pigs or blood-that is the question","volume":"57","author":"Tedder","year":"2017","journal-title":"Transfusion"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Baymakova, M., Terzieva, K., Popov, R., Grancharova, E., Kundurzhiev, T., Pepovich, R., and Tsachev, I. (2021). Seroprevalence of hepatitis E virus infection among blood donors in Bulgaria. Viruses, 16.","DOI":"10.3390\/v13030492"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tracli.2019.06.234","article-title":"Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors","volume":"26","author":"Vuk","year":"2019","journal-title":"Transfus. Clin. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/trf.13028","article-title":"Declining prevalence of hepatitis E antibodies among Danish blood donors","volume":"55","author":"Holm","year":"2015","journal-title":"Transfusion"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.28436","article-title":"A nationwide survey of hepatitis E viral infection in French blood donors","volume":"63","author":"Mansuy","year":"2016","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1128\/JCM.01119-12","article-title":"Novel approach for detection of hepatitis E virus infection in German blood donors","volume":"50","author":"Vollmer","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_49","first-page":"413","article-title":"A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors","volume":"16","author":"Spada","year":"2018","journal-title":"Blood Transfus."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"30299","DOI":"10.2807\/1560-7917.ES.2016.21.30.30299","article-title":"High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014","volume":"21","author":"Lucarelli","year":"2016","journal-title":"Euro Surveill."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"20550","DOI":"10.2807\/1560-7917.ES2013.18.31.20550","article-title":"Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012","volume":"18","author":"Slot","year":"2013","journal-title":"Euro Surveill."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/trf.13402","article-title":"Incidence and duration of hepatitis E virus infection in Dutch blood donors","volume":"56","author":"Hogema","year":"2016","journal-title":"Transfusion"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/trf.14531","article-title":"Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland","volume":"58","author":"Grabarczyk","year":"2018","journal-title":"Transfusion"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.12929","article-title":"Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain)","volume":"55","author":"Sauleda","year":"2015","journal-title":"Transfusion"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1128\/JCM.02343-15","article-title":"Diagnostic performance of five assays for anti-hepatitis E virus IgG and IgM in a large cohort study","volume":"54","author":"Norder","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1423-0410.2011.01583.x","article-title":"Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States","volume":"103","author":"Baylis","year":"2012","journal-title":"Vox Sang."},{"key":"ref_57","unstructured":"Honkanen, E. (2018). Prevalence of Hepatitis E Virus in Finnish Slaughterhouses. [Master\u2019s thesis, University of Helsinki]."},{"key":"ref_58","unstructured":"Mitronen, A. (2021). Prevalence of Hepatitis E Virus in Finnish Beef. [Master\u2019s thesis, University of Helsinki]."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/3\/484\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:58:31Z","timestamp":1760122711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/3\/484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,18]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["pathogens12030484"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12030484","relation":{},"ISSN":["2076-0817"],"issn-type":[{"type":"electronic","value":"2076-0817"}],"subject":[],"published":{"date-parts":[[2023,3,18]]}}}